The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ashapura Minechem Ltd's Overseas Subsidiary has entered into a long-term Memorandum of Understanding (MOU) with China Railway, a Global Fortune 500 Company, to jointly develop its Fako bauxite ...

Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Swedish immuno-oncology firm Alligator Bioscience (STO: ATORX) saw its shares jump more than 13% to 0.26 kronor this morning, as it announced the positive outcome of regulatory interactions with the ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Image courtesy of Colossal Biosciences.(Colossal Biosciences) Colossal Biosciences announced Wednesday it had reached a $10 billion valuation, putting it in rare territory among Texas startups.

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA Holdings, Inc. (“TBUSH”) today announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

Vivanza Biosciences Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure... We hereby wish to inform you that the Company has not ...

Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in an attempt to re-introduce extinct animals, hopes to bring that tusked beast back in the world by late 2028.